drugset
drugset / Trial / NCT00470483

A Study To Compare Emotional Changes In Subjects With Social Anxiety Disorder

NCT00470483 ↗

Phase 1 Completed 56 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

To compare by neuroimaging techniques the way Social Anxiety patients respond to public speaking before and after a drug administration

Timeline

Start
2007-01-22
Primary completion
2009-01-07
Completion
2009-01-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Paroxetine Small molecule — —

Indications

social phobia